Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04FXD
|
|||
Former ID |
DNC005120
|
|||
Drug Name |
CYANATE
|
|||
Synonyms |
cyanate; ISOCYANATE; UNII-YML51WA0FW; YML51WA0FW; 661-20-1; 71000-82-3; UN2206; Cyanate ion(1-); Isocyanate ion(1-); Isocyanate ion (1-); Isocyanic acid, ion(1-); isocynate; Zyanat; Cyanat; carbonyl amide; hydrogen cyanate; UN3080; nitridooxidocarbonate(1-); AC1L2XX2; OCN(-); CHEBI:29195; CTK5I4582; CTK2H4173; BDBM26982; CNO(-1); IQPQWNKOIGAROB-UHFFFAOYSA-N; XLJMAIOERFSOGZ-UHFFFAOYSA-M; AC1Q2283; BDBM50098562; [C(N)O](-); Isocyanates, toxic, n.o.s. or isocyanate solutions, toxic, n.o.s., Fp 61 C and Bp 300 C; Isocyanates, toxic, n.o.s. o
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
CNO-
|
|||
Canonical SMILES |
C(=[N-])=O
|
|||
InChI |
1S/CNO/c2-1-3/q-1
|
|||
InChIKey |
IQPQWNKOIGAROB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 71000-82-3
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:29195
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase I (CA-I) | Target Info | Inhibitor | [1] |
KEGG Pathway | Nitrogen metabolism | |||
Pathwhiz Pathway | Gastric Acid Production | |||
Pathway Interaction Database | C-MYB transcription factor network | |||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
Erythrocytes take up oxygen and release carbon dioxide | ||||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Reversible Hydration of Carbon Dioxide | |||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5769-73. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.